Company Overview

IntelliCyt® Corporation develops, manufactures and markets innovative screening solutions for drug discovery and life science research. Founded in 2006 by life science entrepreneurs and leading scientists, IntelliCyt Corporation was the first to commercialize a true high throughput flow cytometry screening platform that has found application in the areas of biologics, small molecule discovery, in vitro toxicology as well as other high profile research areas from biomarkers to stem cells.

IntelliCyt has brought together a highly experienced, diverse team focused exclusively on creating better tools for cell-based screening. Based on the power of flow cytometry, an essential technology used in AIDS and cancer research, antibody development and clinical diagnosis for the last thirty years, our patented technology expands the utility of flow cytometry far beyond current capabilities.

The IntelliCyt platform includes system hardware, software, informatics, consumables, and reagents and provides the capacity, reliability, and ease of use required for the most demanding discovery efforts. Current products address two key markets:

The HyperCyt® System is a “screening enablement” add-on that addresses the large and growing flow cytometry installed base.

The HTFC® Screening System is an integrated platform with onboard flow cytometry detection that addresses the emerging suspension screening market across the life sciences.